Education Library

Resources for Health Care Professionals

Filter

Filter Results

Condition

Audience

Topic

Type

FAQ: Is There Randomized Controlled Trial Data Available for Impella® Heart Pump Use in Cardiogenic Shock?

FAQ: Is There Randomized Controlled Trial Data Available for Impella® Heart Pump Use in Cardiogenic Shock?

This FAQ discusses the challenges of obtaining RCT data for cardiogenic shock and presents the clinical data that is currently available and ongoing.

Managing Impella® Position Using Imaging and the Automated Impella Controller™

Managing Impella® Position Using Imaging and the Automated Impella Controller™

Jo Kajewski, advanced Impella trainer, discusses how Impella should appear on baseline echo and steps for repositioning Impella if a positioning alarm occur. 

Calculating Total Heparin Rate

Calculating Total Heparin Rate

Learn how to account for Impella® delivered heparin when calculating the total heparin dose for a patient supported with an Impella heart pump. 

Developing Best Practices for Managing AMI Cardiogenic Shock

Developing Best Practices for Managing AMI Cardiogenic Shock

Presenting the NCSI algorithm, William O’Neill, MD, emphasizes the importance of supporting patient quickly.

Discover New Data on Protected PCI versus Bailout PCI

Discover New Data on Protected PCI versus Bailout PCI

Alexander Truesdell, MD, discusses Protected PCI versus bailout PCI using data from the cVAD Study and the PROTECT III study. 

Tips, Tricks and Techniques for High-Risk PCI

Tips, Tricks and Techniques for High-Risk PCI

Amir Kaki, MD discusses tips, tricks and techniques for high-risk PCI including access, implant, explant, closure, and complications and sheath management.

Learn How Impella® Affects Hemodynamics

Learn How Impella® Affects Hemodynamics

Jo Kajewski, global Impella trainer, uses a bedside monitor simulator to demonstrate how the Impella heart pump affects a patient's hemodynamics.

PROTECT Series of Clinical Studies Provides Mounting Evidence for Impella® Support in High-Risk PCI

PROTECT Series of Clinical Studies Provides Mounting Evidence for Impella® Support in High-Risk PCI

This article discusses clinical data from the PROTECT II RCT and the PROTECT III study supporting the use of Impella in high-risk PCI.

Amin Analysis: Review of Trends, Variation and Outcomes in Impella® Use

Amin Analysis: Review of Trends, Variation and Outcomes in Impella® Use

Seth Bilazarian, MD, reviews the shortcomings of the Amin, et al., analysis presented at AHA 2019.

How Do Bleeding Rates with Impella® Compare to Bleeding Rates Associated With Other Forms of Mechanical Circulatory Support?

How Do Bleeding Rates with Impella® Compare to Bleeding Rates Associated With Other Forms of Mechanical Circulatory Support?

This FAQ discusses bleeding rates associated with mechanical circulatory support and vascular access and closure techniques for successfully managing bleeding.

Techniques to Reduce Bleeding with Large Bore Access Devices

Techniques to Reduce Bleeding with Large Bore Access Devices

Amir Kaki, MD, discusses techniques and best practices for access and closure to reduce bleeding and complications with large-bore access devices.

Top Cardiogenic Shock Treatment Objectives and Device Options

Top Cardiogenic Shock Treatment Objectives and Device Options

The goals of cardiogenic shock treatment are to restore blood flow and protect organs from damage. Learn more about signs, symptoms and treatment options.

NCSI Study: About 40% of AMICS Patients Develop Right Ventricular Dysfunction

NCSI Study: About 40% of AMICS Patients Develop Right Ventricular Dysfunction

Babar Basir, DO, discusses NCSI study findings on right ventricular dysfunction in AMI cardiogenic shock.

Looking to Clinical Evidence in Cardiogenic Shock

Looking to Clinical Evidence in Cardiogenic Shock

William O’Neill, MD discusses cardiogenic shock treatment in light of the lack of randomized, controlled clinical trial data for cardiogenic shock.

Door-to-Unload (DTU) in STEMI Trial Summary: Pilot Trial and Pivotal Trial Design

Door-to-Unload (DTU) in STEMI Trial Summary: Pilot Trial and Pivotal Trial Design

Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].

The Protected PCI community
is now on HeartRecovery.com

Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
Explore Now